| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.5 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |